BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 33020067)

  • 1. In Vitro Characterization of Ertugliflozin Metabolism by UDP-Glucuronosyltransferase and Cytochrome P450 Enzymes.
    Lapham K; Callegari E; Cianfrogna J; Lin J; Niosi M; Orozco CC; Sharma R; Goosen TC
    Drug Metab Dispos; 2020 Dec; 48(12):1350-1363. PubMed ID: 33020067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Kinetic Characterization of Axitinib Metabolism.
    Zientek MA; Goosen TC; Tseng E; Lin J; Bauman JN; Walker GS; Kang P; Jiang Y; Freiwald S; Neul D; Smith BJ
    Drug Metab Dispos; 2016 Jan; 44(1):102-14. PubMed ID: 26512042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clopidogrel Carboxylic Acid Glucuronidation is Mediated Mainly by UGT2B7, UGT2B4, and UGT2B17: Implications for Pharmacogenetics and Drug-Drug Interactions
    Kahma H; Filppula AM; Neuvonen M; Tarkiainen EK; Tornio A; Holmberg MT; Itkonen MK; Finel M; Neuvonen PJ; Niemi M; Backman JT
    Drug Metab Dispos; 2018 Feb; 46(2):141-150. PubMed ID: 29138287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxychloroquine is Metabolized by Cytochrome P450 2D6, 3A4, and 2C8, and Inhibits Cytochrome P450 2D6, while its Metabolites also Inhibit Cytochrome P450 3A
    Paludetto MN; Kurkela M; Kahma H; Backman JT; Niemi M; Filppula AM
    Drug Metab Dispos; 2023 Mar; 51(3):293-305. PubMed ID: 36446607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450 2B6 and UDP-Glucuronosyltransferase Enzyme-Mediated Clearance of Ciprofol (HSK3486) in Humans: The Role of Hepatic and Extrahepatic Metabolism.
    Zhou Y; Dong H; Fan J; Zhu M; Liu L; Wang Y; Tang P; Chen X
    Drug Metab Dispos; 2024 Jan; 52(2):106-117. PubMed ID: 38071562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of oxycodone in vitro metabolism by human cytochromes P450 and UDP-glucuronosyltransferases.
    Romand S; Spaggiari D; Marsousi N; Samer C; Desmeules J; Daali Y; Rudaz S
    J Pharm Biomed Anal; 2017 Sep; 144():129-137. PubMed ID: 27692933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trans-3'-hydroxycotinine O- and N-glucuronidations in human liver microsomes.
    Yamanaka H; Nakajima M; Katoh M; Kanoh A; Tamura O; Ishibashi H; Yokoi T
    Drug Metab Dispos; 2005 Jan; 33(1):23-30. PubMed ID: 15470160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of human UGT2B7 as the major isoform involved in the O-glucuronidation of chloramphenicol.
    Chen M; LeDuc B; Kerr S; Howe D; Williams DA
    Drug Metab Dispos; 2010 Mar; 38(3):368-75. PubMed ID: 20008037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct comparison of UDP-glucuronosyltransferase and cytochrome P450 activities in human liver microsomes, plated and suspended primary human hepatocytes from five liver donors.
    den Braver-Sewradj SP; den Braver MW; Baze A; Decorde J; Fonsi M; Bachellier P; Vermeulen NPE; Commandeur JNM; Richert L; Vos JC
    Eur J Pharm Sci; 2017 Nov; 109():96-110. PubMed ID: 28778465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro characterization of the metabolic pathways and cytochrome P450 inhibition and induction potential of BMS-690514, an ErbB/vascular endothelial growth factor receptor inhibitor.
    Hong H; Su H; Ma L; Yao M; Iyer RA; Humphreys WG; Christopher LJ
    Drug Metab Dispos; 2011 Sep; 39(9):1658-67. PubMed ID: 21673131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Liver Microsomes Immobilized on Magnetizable Beads: A Novel Approach to Study In Vitro Drug Metabolism.
    Horspool AM; Wang T; Scaringella YS; Taub ME; Chan TS
    Drug Metab Dispos; 2020 Aug; 48(8):645-654. PubMed ID: 32474441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human drug-metabolising cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in vitro by uremic toxins.
    Barnes KJ; Rowland A; Polasek TM; Miners JO
    Eur J Clin Pharmacol; 2014 Sep; 70(9):1097-106. PubMed ID: 24954688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Charactering the metabolism of cryptotanshinone by human P450 enzymes and uridine diphosphate glucuronosyltransferases in vitro.
    Zeng J; Fan YJ; Tan B; Su HZ; Li Y; Zhang LL; Jiang J; Qiu FR
    Acta Pharmacol Sin; 2018 Aug; 39(8):1393-1404. PubMed ID: 29417949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucuronidation of mono(2-ethylhexyl) phthalate in humans: roles of hepatic and intestinal UDP-glucuronosyltransferases.
    Hanioka N; Kinashi Y; Tanaka-Kagawa T; Isobe T; Jinno H
    Arch Toxicol; 2017 Feb; 91(2):689-698. PubMed ID: 27071666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselective glucuronidation of propranolol in human and cynomolgus monkey liver microsomes: role of human hepatic UDP-glucuronosyltransferase isoforms, UGT1A9, UGT2B4 and UGT2B7.
    Hanioka N; Hayashi K; Shimizudani T; Nagaoka K; Koeda A; Naito S; Narimatsu S
    Pharmacology; 2008; 82(4):293-303. PubMed ID: 18936551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro metabolism, reaction phenotyping, enzyme kinetics, CYP inhibition and induction potential of ataluren.
    Kong R; Ma J; Hwang S; Moon YC; Welch EM; Weetall M; Colacino JM; Almstead N; Babiak J; Goodwin E
    Pharmacol Res Perspect; 2020 Apr; 8(2):e00576. PubMed ID: 32196986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cytochrome P450 enzymes and uridine 5'-diphospho-glucuronosyltransferases by vicagrel in human liver microsomes: A prediction of potential drug-drug interactions.
    Liu S; Wang Z; Chan E; Zhao Y; Kang J; Zhang X; Tian X
    Chem Biol Interact; 2022 Jan; 352():109775. PubMed ID: 34910929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
    Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
    Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of human hepatic UGT1A1, UGT2B4, and UGT2B7 in the glucuronidation of carvedilol.
    Ohno A; Saito Y; Hanioka N; Jinno H; Saeki M; Ando M; Ozawa S; Sawada J
    Drug Metab Dispos; 2004 Feb; 32(2):235-9. PubMed ID: 14744946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regioselective glucuronidation of the isoflavone calycosin by human liver microsomes and recombinant human UDP-glucuronosyltransferases.
    Ruan JQ; Yan R
    Chem Biol Interact; 2014 Sep; 220():231-40. PubMed ID: 25044472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.